Peak XV and Nexus Venture Partners are set to rake in manifold returns as insurtech company Turtlemint goes public. This and more in today’...

Vishal Mega Mart shares made a strong market debut, listing with a 41% premium over the IPO price at Rs 110 on BSE in December 2024. Althou...

Jaiprakash Associates is set to be delisted from the BSE and NSE from June 18 following the completion of insolvency proceedings and Adani ...

Vedanta's Anil Agarwal is listing four companies simultaneously. This move aims to unlock significant growth potential across its businesse...

India's market regulator, SEBI, plans to review its delisting rules. This move aims to simplify capital market processes for businesses. SE...

Coca-Cola may list on Indian stock exchanges next year, a significant shift after 50 years. This move could expose inflated valuations due ...

Binance is democratizing pre-IPO price discovery with its new Pre-IPO Perpetual Contracts. These products allow eligible users to speculate...

Wall Street anticipates SpaceX's IPO, but recent data shows many large debuts have lagged the S&P 500. Investors buying at IPO prices have ...

A Reuters analysis of the 50 largest IPOs over the past five years found that most underperformed the S&P 500 despite strong debut enthusia...

As part of the delisting process, the counter offer bidding period for public shareholders of Shreyas Shipping at Rs 400 per share will sta...

The total number of shares validly tendered by the public shareholders in the delisting offer is 125.47 crore, which is less than the minim...

The reverse book building process of Hexaware Technologies, the first delisting offer by a private equity player in India opened on Wednesd...

While some have advised 'hold' till the time of price discovery, others have recommended exit at the current market price.

Fresenius Kabi Oncology today said Securities Appellate Tribunal (SAT) has granted it an extension of two months to complete its delisting ...

Promoters of healthcare services firm Fresenius Kabi Oncology today made a delisting offer to acquire all publicly held shares for about Rs...

If Alfa Laval accepts this price, it will have to pay around Rs 785 crore compared to Rs 417 crore that it had set aside for the delisting.

It is one of the largest first day responses for the delisting offers on day one in the recent past, the company claimed in a statement iss...